Arcus Biosciences, Inc. 8-K Report: Key Updates for Investors (Feb 15, 2025)

Based on the provided section of the financial report, here are the key insights and important information extracted:

1. Company Information:

• Name: Arcus Biosciences, Inc.
• Incorporation: Delaware (DE)
• CIK: 0001724521
• SEC File Number: 001-38419
• EIN: 47-3898435
• Address: 3928 Point Eden Way, Hayward, CA 94545
• Phone Number: (510) 694-6200

2. Report Type:

• Filing Type: 8-K (a report of unscheduled material events or corporate changes)

3. Date of Filing:

• Filing Date: February 15, 2025

4. Stock Information:

• Common Stock: Par Value $0.0001 per share
• Ticker Symbol: RCUS
• Exchange: NYSE (New York Stock Exchange)

5. Context and Time Frame:

• Period of Report: The report covers the date of February 15, 2025.

This information serves as a summary of the corporate identity, regulatory filing type, and pertinent details regarding the company's stock, which are crucial for investors and analysts assessing the company's compliance and market presence.